The proposed regulator would mirror existing sectoral authorities such as IRDAI for insurance, SEBI for capital markets, and ...

Summit Therapeutics nears a $15B AstraZeneca deal for ivonescimab, targeting a $90B market. See more on the potential and ...

Brazil is experiencing a regulatory revolution that is fundamentally transforming its medical device clinical trial landscape ...

A new study by investigators from Europe, including the Netherlands and the United Kingdom (UK), has shed light on ...

In this week’s edition of InnovationRx, we look at the health impact of the Republican spending bill, a startup that built a hospital in India to test its AI software, the impact of the vaccine panel ...

The results of technology research and development must find their way into the published literature. New models of regulation could help.